| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5197240
Max Phase: Preclinical
Molecular Formula: C18H13BrN2O3S
Molecular Weight: 417.28
Associated Items:
Representations
Canonical SMILES: Cc1ccc(C(=O)Oc2ccc(Br)cc2/C=C2\SC(N)=NC2=O)cc1
Standard InChI: InChI=1S/C18H13BrN2O3S/c1-10-2-4-11(5-3-10)17(23)24-14-7-6-13(19)8-12(14)9-15-16(22)21-18(20)25-15/h2-9H,1H3,(H2,20,21,22)/b15-9-
Standard InChI Key: HIQZARMNAVZCCO-DHDCSXOGSA-N
Associated Targets(Human)
Xanthine dehydrogenase 1038 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 417.28 | Molecular Weight (Monoisotopic): 415.9830 | AlogP: 3.91 | #Rotatable Bonds: 3 |
| Polar Surface Area: 81.75 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 2.85 | CX LogP: 4.41 | CX LogD: 4.41 |
| Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.47 | Np Likeness Score: -1.19 |
References
| 1. Zhang L, Tian J, Cheng H, Yang Y, Yang Y, Ye F, Xiao Z.. (2022) Identification of novel xanthine oxidase inhibitors via virtual screening with enhanced characterization of molybdopterin binding groups., 230 [PMID:35063733] [10.1016/j.ejmech.2022.114101] |
Source
Source(1):